FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199486036> ?p ?o ?g. }

• W3199486036 endingPage "3682" @default.
• W3199486036 startingPage "3668" @default.
• W3199486036 abstract "Ovarian carcinoma (OC) is usually diagnosed at an advanced stage, necessitating a multimodal approach that includes surgery and systemic therapy. The incidence of OC is approximately five times higher in women over 65 years of age. Cardiovascular comorbidities and type 2 diabetes mellitus, both prevalent at this age, can influence therapeutic strategy and have an adverse effect on survival.Our study aimed to determine the impact of cardiovascular diseases and diabetes mellitus on survival in advanced ovarian cancer.From 2004 to 2012, we retrospectively studied 104 patients with advanced epithelial ovarian cancer (FIGO stage II-IV) who underwent surgical treatment at the Gynecology Clinic, St. Anna University Hospital, Varna, Bulgaria. Patients were followed for an average of 90 (52-129) months. We divided the study population into two groups: those with concurrent cardiovascular diseases and type 2 diabetes mellitus (CVD) and those without these comorbidities (No-CVD group). Overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were compared between groups using Kaplan-Meier survival analysis. Cardiovascular comorbidities and diabetes mellitus were evaluated for their prognostic value for survival using multivariate Cox proportional regression analysis adjusted for age, stage of OC, grade and histological type of the tumor, ascites presence, residual tumor size (RT), performance status, and type of hysterectomy.The Kaplan-Meier analysis showed reduced OS and DSS in the CVD group compared to the No-CVD group. The median OS was 24.5 months (95% CI 18.38 months) and 38 months (95% CI 26, not reached), respectively (Log-rank p = 0.045). The median DSS was 25.5 months (95% CI 19.39 months) and 48 months (95% CI 28, not reached), respectively (Log-rank p = 0.033). The Cox regression multivariate analysis established a lower (by 68%) overall survival rate for the CVD patient group than the No-CVD group, approaching statistical significance (HR 1.68, 95% CI 0.99, 2.86, p = 0.055). Cardiovascular diseases and diabetes were associated with a 79% reduction in DSS (HR 1.79, 95% CI 1.02, 3.13, p = 0.041) and a twofold increase in the risk of disease progression (HR 2.05, 95% CI 1.25, 3.37, p = 0.005).According to our study, cardiovascular comorbidities and diabetes may adversely affect OC survival. Optimal control of cardiovascular diseases, diabetes mellitus, and their risk factors may be beneficial for patients with advanced OC. Further research involving a larger patient population is necessary to establish these comorbidities as independent prognostic factors." @default.
• W3199486036 created "2021-09-27" @default.
• W3199486036 creator A5010747021 @default.
• W3199486036 creator A5034529420 @default.
• W3199486036 creator A5044487744 @default.
• W3199486036 creator A5065717708 @default.
• W3199486036 creator A5072396973 @default.
• W3199486036 creator A5090677273 @default.
• W3199486036 date "2021-09-21" @default.
• W3199486036 modified "2023-09-27" @default.
• W3199486036 title "Survival in Advanced Epithelial Ovarian Cancer Associated with Cardiovascular Comorbidities and Type 2 Diabetes Mellitus" @default.
• W3199486036 cites W1985579946 @default.
• W3199486036 cites W1988943434 @default.
• W3199486036 cites W2069124281 @default.
• W3199486036 cites W2083704677 @default.
• W3199486036 cites W2085321881 @default.
• W3199486036 cites W2093287455 @default.
• W3199486036 cites W2106275439 @default.
• W3199486036 cites W2157494695 @default.
• W3199486036 cites W2162802024 @default.
• W3199486036 cites W2168083201 @default.
• W3199486036 cites W2248741218 @default.
• W3199486036 cites W2298991506 @default.
• W3199486036 cites W2326297673 @default.
• W3199486036 cites W2427507452 @default.
• W3199486036 cites W2466225656 @default.
• W3199486036 cites W2596464823 @default.
• W3199486036 cites W2621001223 @default.
• W3199486036 cites W2624040118 @default.
• W3199486036 cites W2792130869 @default.
• W3199486036 cites W2885177076 @default.
• W3199486036 cites W2886482717 @default.
• W3199486036 cites W2905400717 @default.
• W3199486036 cites W2922186011 @default.
• W3199486036 cites W2999417355 @default.
• W3199486036 cites W3034761698 @default.
• W3199486036 cites W3109819734 @default.
• W3199486036 cites W3131704889 @default.
• W3199486036 cites W3147142721 @default.
• W3199486036 cites W3148985741 @default.
• W3199486036 cites W3189615500 @default.
• W3199486036 cites W4246133235 @default.
• W3199486036 cites W853817335 @default.
• W3199486036 doi "https://doi.org/10.3390/curroncol28050313" @default.
• W3199486036 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8482267" @default.
• W3199486036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34590605" @default.
• W3199486036 hasPublicationYear "2021" @default.
• W3199486036 type Work @default.
• W3199486036 sameAs 3199486036 @default.
• W3199486036 citedByCount "3" @default.
• W3199486036 countsByYear W31994860362022 @default.
• W3199486036 countsByYear W31994860362023 @default.
• W3199486036 crossrefType "journal-article" @default.
• W3199486036 hasAuthorship W3199486036A5010747021 @default.
• W3199486036 hasAuthorship W3199486036A5034529420 @default.
• W3199486036 hasAuthorship W3199486036A5044487744 @default.
• W3199486036 hasAuthorship W3199486036A5065717708 @default.
• W3199486036 hasAuthorship W3199486036A5072396973 @default.
• W3199486036 hasAuthorship W3199486036A5090677273 @default.
• W3199486036 hasBestOaLocation W31994860361 @default.
• W3199486036 hasConcept C10515644 @default.
• W3199486036 hasConcept C120665830 @default.
• W3199486036 hasConcept C121332964 @default.
• W3199486036 hasConcept C121608353 @default.
• W3199486036 hasConcept C126322002 @default.
• W3199486036 hasConcept C134018914 @default.
• W3199486036 hasConcept C143998085 @default.
• W3199486036 hasConcept C146357865 @default.
• W3199486036 hasConcept C151730666 @default.
• W3199486036 hasConcept C2779134260 @default.
• W3199486036 hasConcept C2780427987 @default.
• W3199486036 hasConcept C2780496750 @default.
• W3199486036 hasConcept C2908647359 @default.
• W3199486036 hasConcept C2910068830 @default.
• W3199486036 hasConcept C50382708 @default.
• W3199486036 hasConcept C555293320 @default.
• W3199486036 hasConcept C61511704 @default.
• W3199486036 hasConcept C71924100 @default.
• W3199486036 hasConcept C86803240 @default.
• W3199486036 hasConcept C99454951 @default.
• W3199486036 hasConceptScore W3199486036C10515644 @default.
• W3199486036 hasConceptScore W3199486036C120665830 @default.
• W3199486036 hasConceptScore W3199486036C121332964 @default.
• W3199486036 hasConceptScore W3199486036C121608353 @default.
• W3199486036 hasConceptScore W3199486036C126322002 @default.
• W3199486036 hasConceptScore W3199486036C134018914 @default.
• W3199486036 hasConceptScore W3199486036C143998085 @default.
• W3199486036 hasConceptScore W3199486036C146357865 @default.
• W3199486036 hasConceptScore W3199486036C151730666 @default.
• W3199486036 hasConceptScore W3199486036C2779134260 @default.
• W3199486036 hasConceptScore W3199486036C2780427987 @default.
• W3199486036 hasConceptScore W3199486036C2780496750 @default.
• W3199486036 hasConceptScore W3199486036C2908647359 @default.
• W3199486036 hasConceptScore W3199486036C2910068830 @default.
• W3199486036 hasConceptScore W3199486036C50382708 @default.
• W3199486036 hasConceptScore W3199486036C555293320 @default.
• W3199486036 hasConceptScore W3199486036C61511704 @default.
• W3199486036 hasConceptScore W3199486036C71924100 @default.

• next